Mausbach BT, Decastro G, Schwab RB, Tiamson-Kassab M, Irwin SA (2020) Healthcare use and costs in adult cancer patients with anxiety and depression. Depress Anxiety 37(9):908–915. https://doi.org/10.1002/da.23059
Article PubMed PubMed Central Google Scholar
Mausbach BT, Irwin SA (2017) Depression and healthcare service utilization in patients with cancer. Psychooncology 26(8):1133–1139. https://doi.org/10.1002/pon.4133
Pinquart M, Duberstein PR (2010) Depression and cancer mortality: a meta-analysis. Psychol Med 40(11):1797–1810. https://doi.org/10.1017/S0033291709992285
Article CAS PubMed PubMed Central Google Scholar
Spiegel D, Giese-Davis J (2003) Depression and cancer: mechanisms and disease progression. BiolPsychiatry. 54(3):269–282
Satin JR, Linden W, Phillips MJ (2009) Depression as a predictor of disease progression and mortality in cancer patients. Cancer 115(22):5349–5361. https://doi.org/10.1002/cncr.24561
Article CAS PubMed Google Scholar
Antoni MH, Lutgendorf SK, Cole SW et al (2006) The influence of bio-behavioural factors on tumour biology: pathways and mechanisms. Nat. Rev. Cancer 6(3):240–248
Article CAS PubMed PubMed Central Google Scholar
Arnold SD, Forman LM, Brigidi BD et al (2008) Evaluation and characterization of generalized anxiety and depression in patients with primary brain tumors. Neuro Oncol 10(2):171–181. https://doi.org/10.1215/15228517-2007-057
Article PubMed PubMed Central Google Scholar
Chambers SK, Grassi L, Hyde MK, Holland J, Dunn J (2015) Integrating psychosocial care into neuro-oncology: challenges and strategies. Front Oncol 5:41. https://doi.org/10.3389/fonc.2015.00041
Article PubMed PubMed Central Google Scholar
Gibson AW, Graber JJ (2021) Distinguishing and treating depression, anxiety, adjustment, and post-traumatic stress disorders in brain tumor patients. Ann Palliat Med 10(1):875–892. https://doi.org/10.21037/apm-20-509
Pelletier G, Verhoef MJ, Khatri N, Hagen N (2002) Quality of life in brain tumor patients: the relative contributions of depression, fatigue, emotional distress, and existential issues. J Neurooncol 57(1):41–49. https://doi.org/10.1023/a:1015728825642
Rooney AG, Carson A, Grant R (2011) Depression in cerebral glioma patients: a systematic review of observational studies. J Natl Cancer Inst 103(1):61–76. https://doi.org/10.1093/jnci/djq458
Rooney AG, McNamara S, Mackinnon M et al (2011) Frequency, clinical associations, and longitudinal course of major depressive disorder in adults with cerebral glioma. J Clin Oncol 29(32):4307–4312. https://doi.org/10.1200/JCO.2011.34.8466
van der Meer PB, Dirven L, Hertler C et al (2023) Depression and anxiety in glioma patients. Neuro-Oncol Pract. https://doi.org/10.1093/nop/npad019
Mainio A, Hakko H, Niemela A, Koivukangas J, Rasanen P (2005) Depression and functional outcome in patients with brain tumors: a population-based 1-year follow-up study. J Neurosurg 103(5):841–847. https://doi.org/10.3171/jns.2005.103.5.0841
Rooney AG, Brown PD, Reijneveld JC, Grant R (2014) Depression in glioma: a primer for clinicians and researchers. J Neurol Neurosurg Psychiatry 85(2):230–235. https://doi.org/10.1136/jnnp-2013-306497
D’Angelo C, Mirijello A, Leggio L et al (2008) State and trait anxiety and depression in patients with primary brain tumors before and after surgery: 1-year longitudinal study. J Neurosurg 108(2):281–286. https://doi.org/10.3171/JNS/2008/108/2/0281
Piil K, Jakobsen J, Christensen KB, Juhler M, Jarden M (2015) Health-related quality of life in patients with high-grade gliomas: a quantitative longitudinal study. J Neurooncol 124(2):185–195. https://doi.org/10.1007/s11060-015-1821-2
Article CAS PubMed Google Scholar
Pringle AM, Taylor R, Whittle IR (1999) Anxiety and depression in patients with an intracranial neoplasm before and after tumour surgery. Br J Neurosurg 13(1):46–51. https://doi.org/10.1080/02688699944177
Article CAS PubMed Google Scholar
Litofsky NS, Farace E, Anderson F Jr et al (2004) Depression in patients with high-grade glioma: results of the glioma outcomes project. Neurosurgery 54(2):358–66. https://doi.org/10.1227/01.neu.0000103450.94724.a2
Tibbs MD, Huynh-Le MP, Reyes A et al (2020) Longitudinal analysis of depression and anxiety symptoms as independent predictors of neurocognitive function in primary brain tumor patients. Int J Radiat Oncol Biol Phys 108(5):1229–1239. https://doi.org/10.1016/j.ijrobp.2020.07.002
Article PubMed PubMed Central Google Scholar
Cella D, Riley W, Stone A et al (2010) The patient-reported outcomes measurement information system (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008. J Clin Epidemiol 63(11):1179–1194. https://doi.org/10.1016/j.jclinepi.2010.04.011
Article PubMed PubMed Central Google Scholar
Terwee CB, Peipert JD, Chapman R et al (2021) Minimal important change (MIC): a conceptual clarification and systematic review of MIC estimates of PROMIS measures. Qual Life Res 30(10):2729–2754. https://doi.org/10.1007/s11136-021-02925-y
Article PubMed PubMed Central Google Scholar
Yost KJ, Eton DT, Garcia SF, Cella D (2011) Minimally important differences were estimated for six patient-reported outcomes measurement information system-cancer scales in advanced-stage cancer patients. J Clin Epidemiol 64(5):507–516. https://doi.org/10.1016/j.jclinepi.2010.11.018
Article PubMed PubMed Central Google Scholar
Thavarajah N, Bedard G, Zhang L et al (2014) Psychometric validation of the functional assessment of cancer therapy–brain (FACT-Br) for assessing quality of life in patients with brain metastases. Support Care Cancer 22(4):1017–1028. https://doi.org/10.1007/s00520-013-2060-8
Weitzner MA, Meyers CA, Gelke CK, Byrne KS, Cella DF, Levin VA (1995) The functional assessment of cancer therapy (FACT) scale. Development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors. Cancer 75(5):1151–1161
Article CAS PubMed Google Scholar
Little RJA (1998) A test of missing completely at random for multivariate data with missing values. J Am Stat Assoc 83(404):1198–1202. https://doi.org/10.1080/01621459.1988.10478722
Multiple regression: Testing and interpreting interactions. Thousand Oaks, CA, US.
McNeish D, Matta T (2018) Differentiating between mixed-effects and latent-curve approaches to growth modeling. Behav Res Methods 50(4):1398–1414. https://doi.org/10.3758/s13428-017-0976-5
Lai JS, Beaumont JL, Kupst MJ et al (2020) Symptom burden trajectories experienced by patients with brain tumors. Cancer 126(14):3341–3351. https://doi.org/10.1002/cncr.32879
Liu F, Huang J, Zhang L et al (2018) Screening for distress in patients with primary brain tumor using distress thermometer: a systematic review and meta-analysis. BMC Cancer 18(1):124. https://doi.org/10.1186/s12885-018-3990-9
Article PubMed PubMed Central Google Scholar
Baker PD, Bambrough J, Fox JRE, Kyle SD (2016) Health-related quality of life and psychological functioning in patients with primary malignant brain tumors: a systematic review of clinical, demographic and mental health factors. Neurooncol Pract 3(4):211–221. https://doi.org/10.1093/nop/npv042
McDonald PG, Antoni MH, Lutgendorf SK et al (2005) A biobehavioral perspective of tumor biology. Discov Med 5(30):520–526
PubMed PubMed Central Google Scholar
Anderson J, Burney S, Brooker JE et al (2014) Anxiety in the management of localised prostate cancer by active surveillance. BJU Int 114(Suppl 1):55–61. https://doi.org/10.1111/bju.12765
Wagner LI, Spiegel D, Pearman T (2013) Using the science of psychosocial care to implement the new American college of surgeons commission on cancer distress screening standard. J Natl Compr Canc Netw 11(2):214–221. https://doi.org/10.6004/jnccn.2013.0028
Institute of Medicine Committee on Psychosocial Services to Cancer Patients/Families in a Community S. The National Academies Collection: Reports funded by National Institutes of Health. In: Adler NE, Page AEK, eds. Cancer Care for the Whole Patient: Meeting Psychosocial Health Needs. National Academies Press (US) Copyright © 2008, National Academy of Sciences.; 2008.
(1999) NCCN practice guidelines for the management of psychosocial distress. National Comprehensive Cancer Network. Oncology (Williston Park). 13(5a):113–47
Beevers Z, Hussain S, Boele FW, Rooney AG (2020) Pharmacological treatment of depression in people with a primary brain tumour. Cochrane Database Syst Rev 7(7):32. https://doi.org/10.1002/14651858.CD006932.pub4
Kangas M (2015) Psychotherapy interventions for managing anxiety and depressive symptoms in adult brain tumor patients: a scoping review. Front Oncol 5:116. https://doi.org/10.3389/fonc.2015.00116
留言 (0)